|
|
|
Volumn 18, Issue 8, 2008, Pages 1169-1175
|
|
Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ANTIRHEUMATIC AGENT;
IMMUNOGLOBULIN G;
INFLIXIMAB;
METHOTREXATE;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
DRUG COMBINATION;
HUMAN;
PHYSIOLOGY;
REVIEW;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOGLOBULIN G;
METHOTREXATE;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 53049083207
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (20)
|
